- Home
- » Tags
- » Paromomycin
Top View
- Protocol for Non-Interventional Studies Based on Existing Data TITLE PAGE Document Number: C30445781-01
- Point Prevalence Survey of Healthcare-Associated Infections and Antimicrobial Use in European Acute Care Hospitals
- Differential Effects of Paromomycin on Ribosomes of Leishmania Mexicana and Mammalian Cellsᰔ Marisa M
- Drugs for Parasitic Infections
- Reseptregisteret 2014–2018 the Norwegian Prescription Database 2014–2018
- Ribosomal Assembly Influenced by Growth in the Presence of Streptomycin (Stra Allele/Protein S12/Ribosomes Modified in Vivo/Misreading/T4 Bacteriophage) ROBERT T
- Drugs for Parasitic Infections (2013 Edition)
- UK-VARSS 2018 Supplementary Material
- Humatin (Paromomycin Sulfate) Capsule
- Manufacturers of Drugs Used to Treat Parasitic
- (EBSR): Drug-Induced Hearing Loss-Aminoglycosides
- Kanamycin Sulfate from Streptomyces Kanamyceticus (K1377)
- Is Paromomycin the Drug of Choice for Eradication of Dientamoeba Fragilis in Adults? ⇑ Jaap J
- Gentamicin Therapy and MT-RNR1 Genotype Laura Dean, MD1 Created: April 29, 2015
- API's PAROMOMYCIN Sulphate
- Paromomycin Is Superior to Metronidazole in Dientamoeba Fragilis Treatment T Ander Burgañaa, Rosa Abellanab, Stanislav Zlatanov Yordanova, Rabee Kazana, A
- Identification of Selective Agents Concentrations for Optimal Plant Regeneration from Transformed Calli and Immature Embryos in Wheat
- A Tale of Two Antibiotics
- Amikacin: Uses, Resistance, and Prospects for Inhibition
- Modified Solid Lipid Nanoparticles Encapsulated with Amphotericin B
- Amebic Meningoencephalitis.Qxd
- Nourseothricin N-Acetyl Transferase (NAT), a New Selectable Marker for Nuclear Gene Expression in Chlamydomonas
- EFFECTIVE 10/01/2014 Version 2014.4E
- Biochemical Basis of Resistance to Hygromycin B in Streptomyces Hygroscopicus - the Producing Organism
- MANAGEMENT of INFECTIOUS DIARRHOEA Gut: First Published As 10.1136/Gut.2003.022103 on 14 January 2004
- Antibiotics, Gastrointestinal Therapeutic Class Review (TCR)
- Scramble: a Study of Its Robustness and Challenges Through Enhancement of Hygromycin B Resistance in a Semi-Synthetic Yeast
- ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
- TRS958.Indd I 12.04.10 16:01 WHO Library Cataloguing-In-Publication Data
- Amikacin (Systemic)
- Essential Medicines WHO Model List (Revised March 2007) Explanatory Notes
- The Development of Oral Amphotericin B to Treat Systemic Fungal and Parasitic Infections: Has the Myth Been Finally Realized?
- Pharmacokinetics and Absorption of Paromomycin and Gentamicin from Topical Creams Used to Treat Cutaneous Leishmaniasis William R
- Antibiotics That Inhibit 30S Or 50S Ribosomal Subunit Formation: Hygromycin B, Quinupristin- Dalfopristin and XRP 2868
- Amikacin (Systemic)
- PAROMOMYCIN, POLYMYXIN B and FURAZOLIDONE in EXPERIMENTAL CHOLERA By
- Supplementary Material UK-VARSS 2019
- Letter to the Editor Topical Paromomycin and Gentamicin for New World Cutaneous Leishmaniasis in Panama
- Guidelines for ATC Classification and DDD Assignment 2021
- Bericht Über Den Vertrieb Von Antibiotika in Der Veterinärmedizin in Österreich 2012–2016
- Editorial Amphotericin B Formulations and Other Drugs for Visceral Leishmaniasis
- Is Paromomycin the Drug of Choice for Eradication of Dientamoeba Fragilis in Adults? ⇑ Jaap J
- Biosynthetic Genes for Aminoglycoside Antibiotics
- Structural Basis for Hygromycin B Inhibition of Protein Biosynthesis
- Real-Time Measurements of Aminoglycoside Effects on Protein Synthesis in Live Cells
- NATIONAL ANTIMICROBIAL GUIDELINES Issued By: National Antimicrobial Sub Committee Effective Date:09/05/2016 Applies To: All Healthcare Facilities in Oman
- Paromomycin (Tissues and Eggs of All Food Producing Species)
- 22 June 2021
- Escherichia Coli
- Amikacin Resistance Associated with a Plasmid-Borne Aminoglycoside Phosphotransferase in Escherichia Coli MICHAEL H
- Microbiology Guide to Interpreting Minimum Inhibitory Concentration (MIC)
- Box 1. Recommended Treatment Regimens for Visceral Leishmaniasis, Ranked by Preference1 Anthroponotic Visceral Leishmaniasis
- Liposomal Amphotericin B (Ambisome) in Refractory Indian VL
- Aminoglycosides: from Antibiotics to Building Blocks for the Synthesis and Development of Gene † Delivery Vehicles
- Paromomycin Production from Streptomyces
- Summary Report on Antimicrobials Dispensed in Public Hospitals
- Biochemical Characterization of Two Cloned Resistance Determinants
- Paromomycin (Pair-Oh-Moe-My-Sin) Description: Oral Antiparasitic Other Names for This Medication: Humatin® Common Dosage Forms: Veterinary: None
- Reflection Paper on Use of Aminoglycosides in Animals in the European Union: Development of Resistance and Impact on Human and Animal Health
- Categorisation of Antibiotics for Use in Animals EMA for Prudent and Responsible Use